These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38589920)

  • 1. How do people who use opioids express their qualities and capacities? An assessment of attitudes, behaviors, and opportunities.
    Ezell JM; Pho MT; Simek E; Ajayi BP; Shetty N; Walters SM
    Harm Reduct J; 2024 Apr; 21(1):79. PubMed ID: 38589920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
    Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G; Strike C
    Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It's Like A Partnership": Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs.
    Dunham K; Rivas C; Medina Blanco P; Kolod B; Salvati C; Clark K; Sue KL; Hagaman A; Weiss JJ
    J Gen Intern Med; 2024 Jul; 39(9):1681-1689. PubMed ID: 38578536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public support for harm reduction: A population survey of Canadian adults.
    Wild TC; Koziel J; Anderson-Baron J; Asbridge M; Belle-Isle L; Dell C; Elliott R; Hathaway A; MacPherson D; McBride K; Pauly B; Strike C; Galovan A; Hyshka E
    PLoS One; 2021; 16(5):e0251860. PubMed ID: 34010338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City.
    Fong C; Mateu-Gelabert P; Ciervo C; Eckhardt B; Aponte-Melendez Y; Kapadia S; Marks K
    Drug Alcohol Depend; 2021 Apr; 221():108589. PubMed ID: 33621804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
    Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
    Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic.
    McGinty EE; Barry CL; Stone EM; Niederdeppe J; Kennedy-Hendricks A; Linden S; Sherman SG
    Prev Med; 2018 Jun; 111():73-77. PubMed ID: 29481827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How understanding and application of drug-related legal instruments affects harm reduction interventions in Cambodia: a qualitative study.
    Tuot S; Ngin C; Pal K; Sou S; Sawez G; Morgan P; Srey M; Chan T; Chhoun P; Golichenko O; Choub SC; Yi S
    Harm Reduct J; 2017 Jun; 14(1):39. PubMed ID: 28629463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I am not a junkie": Social categorization and differentiation among people who use drugs.
    Sibley AL; Baker R; Levander XA; Rains A; Walters SM; Nolte K; Colston DC; Piscalko HM; Schalkoff CA; Bianchet E; Chen S; Dowd P; Jaeb M; Friedmann PD; Fredericksen RJ; Seal DW; Go VF
    Int J Drug Policy; 2023 Apr; 114():103999. PubMed ID: 36905779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
    McKnight C; Des Jarlais DC
    Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.